Billionaire investor Paulson joins Valeant board, shares jump

ReutersFILE PHOTO: A sign for the headquarters of Valeant Pharmaceuticals International Inc is seen in Laval, Quebec June 14, 2016. REUTERS/Christinne Muschi/File Photo. By Svea Herbst-Bayliss. Billionaire investor John Paulson, whose hedge fund firm is the …Hedge fund manager John Paulson joins Valeant’s board after his firm took a nearly $2 billion hit on Valeant ..

Billionaire investor Paulson joins Valeant board, shares jump

ReutersFILE PHOTO: A sign for the headquarters of Valeant Pharmaceuticals International Inc is seen in Laval, Quebec June 14, 2016. REUTERS/Christinne Muschi/File Photo. By Svea Herbst-Bayliss. Billionaire investor John Paulson, whose hedge fund firm is the …Hedge fund manager John Paulson joins Valeant’s board after his firm took a nearly $2 billion hit on Valeant ..

Valeant to sell its iNova Pharma business for $930 mln

Nasdaq(Adds details, background, shares) June 8 (Reuters) – Embattled Canadian drugmaker Valeant Pharmaceuticals International Inc <VRX.TO> <VRX.N> said on Thursday it would sell its iNova Pharmaceuticals business for $930 million in cash as it looks to pay …Valeant Announces Sale of iNova Pharmaceuticals for $930 Million ..

Valeant to sell its iNova Pharmaceuticals business for $930 mILLION

ReutersThe company logo of Valeant Pharmaceuticals International Inc is seen at its headquarters in Laval, Quebec May 19, 2015. REUTERS/Christinne Muschi. Embattled Canadian drugmaker Valeant Pharmaceuticals International Inc (VRX.TO) (VRX.N) said on …Valeant Announces Sale of iNova Pharmaceuticals for $930 Million ..

Valeant to sell iNova unit for $930 mln to repay debt

Nasdaq… * Pacific Equity Partners, Carlyle Group to buy iNova unit * Deal expected to close in H2 2017 * Valeant’s U.S.-listed shares rise 3.5 pct premarket (Adds details) June 8 (Reuters) – Valeant Pharmaceuticals International Inc <VRX.TO> <VRX.N> said Valeant is selling its iNova Pharmaceuticals business for $930 million ..

Valeant is selling its iNova Pharmaceuticals business for $930 million

Business Insider(Reuters) – Embattled Canadian drugmaker Valeant Pharmaceuticals International Inc said on Thursday it would sell its iNova Pharmaceuticals business for $930 million in cash as it looks to pay down debt. The unit, which sells prescription and …Valeant’s sale of iNova is debt neutral, says Evercore analyst ..

Hedge fund manager John Paulson joins Valeant’s board after his firm took a nearly $2 billion hit on Valeant

CNBCJohn Paulson is remembered for making a handful of bad bets on drug makers, including one on Valeant. “I am fully supportive of the strategy and leadership team at Valeant,” Paulson said Monday. According to Forbes, Paulson remains one of the hedge …Valeant Stock Jumps After John Paulson Named to Board ..

Valeant’s stock surges after largest shareholder John Paulson elected to board

Sports PerspectivesShares of Valeant Pharmaceuticals International Inc. VRX, +4.46% surged 5% in premarket trade Monday, after the drug maker said billionaire hedge fund manager John Paulson was elected to its board of directors. Paulson’s hedge fund, Paulson & Co.John Paulson Joins Valeant Board Of Directors ..

Valeant shares jump 5% premarket on news of sale of iNova Pharmaceuticals for $930 million

AmigobullsValeant Pharmaceuticals International Inc. VRX, -3.11% said Thursday it has agreed to sell iNova Pharmaceuticals to a company owned by funds managed by private-equity firms Pacific Equity Partners and The Carlyle Group for $930 million in cash. iNova …Valeant Announces Sale of iNova Pharmaceuticals for $930 Million ..